[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338027-105":59,"doc-detail-338027-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","harnessing-exosomes-as-cancer-biomarkers-in-clinical-oncology","Harnessing exosomes as cancer biomarkers in clinical oncology","","Exosomes are extracellular vesicles that enable cell-to-cell communication by transferring essential macromolecules including proteins, DNA, mRNA, lipids, and miRNA. They are abundant in body fluids such as urine, blood, saliva, and bile, and hold diagnostic value across multiple cancer types. Most regions have not fully implemented exosome-based cancer biomarkers. This review explains how OMICs profiling of exosomes can support clinical detection while replacing costly, mostly invasive imaging or biopsy methods, enabling routine screening and earlier diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/harnessing-exosomes-as-cancer-biomarkers-in-clinical-oncology/338027/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/harnessing-exosomes-as-cancer-biomarkers-in-clinical-oncology/338027.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are exosomes and why are they relevant to cancer biomarkers?","Question",{"text":112,"@type":113},"Exosomes are extracellular vesicles that transport proteins, nucleic acids, lipids, and miRNA between cells. Because they carry molecules characteristic of their source cells, they can reflect cancer-associated changes and support biomarker development.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does exosome-based testing support early cancer detection?",{"text":117,"@type":113},"Early detection is enabled by analyzing exosomal content after cancer cells release exosomes into the bloodstream or other biofluids. This approach aims to identify cancer at a more manageable stage for treatment.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitation does the review highlight about current cancer screening methods?",{"text":121,"@type":113},"Traditional screening methods rely heavily on extensive imaging and biopsy, which are expensive, mostly invasive, and not easily suited for early detection across many cancer types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338027,1790167401,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ghosh et al. Cancer Cell International (2024) 24:278  \n[https://doi.org/10.1186/s12935-024-03464-5](https://doi.org/10.1186/s12935-024-03464-5)  \nCancer Cell International  \n REVIEW Open Access  \nHarnessing exosomes as cancer biomarkers   in clinical oncology  \nSubhrojyoti Ghosh1†, Ramya Lakshmi Rajendran2†, Atharva A. Mahajan3†, Ankita Chowdhury4, Aishi Bera5, Sudeepta Guha6, Kashmira Chakraborty6, Rajanyaa Chowdhury5, Aritra Paul5, Shreya Jha7, Anuvab Dey8, Amit Dubey9,10, Sukhamoy Gorai11, Purbasha Das12, Chae Moon Hong2,13, Anand Krishnan 14*,  \nPrakash Gangadaran2,15* and Byeong‑Cheol Ahn2,13,15*  \nAbstract  \nExosomes are extracellular vesicles well known for facilitating cell‑to‑cell communication by distributing essen‑  \ntial macromolecules like proteins, DNA, mRNA, lipids, and miRNA. These vesicles are abundant in fluids distributed throughout the body, including urine, blood, saliva, and even bile. They are important diagnostic tools for breast, lung, gastrointestinal cancers, etc. However, their application as cancer biomarkers has not yet been implemented in most parts of the world. In this review, we discuss how OMICs profiling of exosomes can be practiced by substituting tra‑ ditional imaging or biopsy methods for cancer detection. Previous methods like extensive imaging and biopsy used for screening were expensive, mostly invasive, and could not easily provide early detection for various types of cancer. Exosomal biomarkers can be utilized for routine screening by simply collecting body fluids from the individual. We anticipate that the use of exosomes will be brought to light by the success of clinical trials investigating their potential to enhance cancer detection and treatment in the upcoming years.  \nKeywords Exosomes, Cancer biomarkers, Clinical signature, Diagnostic tool, Prognostic indicator, Tumor‑derived exosomes, Molecular profiling, Cancer diagnosis  \n†Subhrojyoti Ghosh, Ramya Lakshmi Rajendran and Atharva A. Mahajan contributed equally to this work.  \n*Correspondence: Anand Krishnan [krishnana1@ufs.ac.za](krishnana1@ufs.ac.za)[ ](krishnana1@ufs.ac.za)Prakash Gangadaran [prakashg@knu.ac.kr](prakashg@knu.ac.kr)[ ](prakashg@knu.ac.kr)Byeong‑Cheol Ahn [abc2000@knu.ac.kr](abc2000@knu.ac.kr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by‑nc‑nd/4.0/.  \nGhosh et al. Cancer Cell International (2024) 24:278 Page 2 of 26  \nGraphical Abstract  \nIntroduction  \nIn the era of precision medicine, identifying and validating reliable cancer biomarkers are paramount for early detection, accurate diagnosis, and effective treatment strategies. Exosomes have gained substantial attention among emerging candidates as promising carriers of valuable information in cancer research. Exosomes are tiny extracellular vesicles (EVs) with a diameter ranging from 30 to 150 nm [1]. They are secreted by cells into bodily fluids such as blood, urine, cerebrospinal ","cbCaius0VGrkaysl","https://ap.wps.com/l/cbCaius0VGrkaysl","pdf",3010117,26,"English","# Abstract\n# Introduction\n## Exosomes and precision medicine\n## Early detection using exosomal content\n## Exosome formation and biological roles\n## Exosomes in cancer progression","[{\"question\":\"What are exosomes and why are they relevant to cancer biomarkers?\",\"answer\":\"Exosomes are extracellular vesicles that transport proteins, nucleic acids, lipids, and miRNA between cells. Because they carry molecules characteristic of their source cells, they can reflect cancer-associated changes and support biomarker development.\"},{\"question\":\"How does exosome-based testing support early cancer detection?\",\"answer\":\"Early detection is enabled by analyzing exosomal content after cancer cells release exosomes into the bloodstream or other biofluids. This approach aims to identify cancer at a more manageable stage for treatment.\"},{\"question\":\"What limitation does the review highlight about current cancer screening methods?\",\"answer\":\"Traditional screening methods rely heavily on extensive imaging and biopsy, which are expensive, mostly invasive, and not easily suited for early detection across many cancer types.\"}]","Harnessing exosomes as cancer biomarkers in clinical oncology | PDF",1790021622,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8f44247f0cd25c796e9f29cd829bf59.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ea0781f3b06f2df5667b0bf501c7626.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3dbea44bc3f0ba0494b7757ac34c083.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/398e9591ca70c5bf4e7a073466f4926f.webp",980,1301]